The Marijuana Industry Just Had a Massive Milestone

Trulieve Cannabis is a leading company in the marijuana market, and it's now trading on a major U.S. exchange. As the U.S. government has rescheduled medical marijuana products, it has paved the way for Trulieve to uplist onto the New York Stock Exchange.

The Motley Fool • Jun 16, 2026

Top Performing Leveraged/Inverse ETFs: 05/31/2026

Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.

ETF Trends • Jun 2, 2026

Marijuana Stocks to Watch Before the Next Cannabis Rally

The cannabis sector continues to attract investors seeking long-term growth opportunities in 2026. Although volatility remains high, many marijuana companies are improving operations and cutting costs. At the same time, investors continue watching potential federal reform closely. Rescheduling discussions and banking reform could become major catalysts for the industry.

Dan Ahrens on Pot Stock Outlook & MSOS ETF After Reclassification

Recent news of marijuana's reclassification is just the first step of many, according to Dan Ahrens of AdvisorShares. Dan talks about the catalysts he sees this summer and the upside he expects to see in marijuana-tied stocks.

US Reclassifies Weed: Can Cannabis ETFs Give Your Portfolio a New High?

Medical marijuana's US reclassification revives cannabis ETFs like WEED, with tax relief and reform hopes fueling sharp gains across the sector.

Zacks Investment Research • May 14, 2026

3 Top Picks For Marijuana Stocks Investors To See Profits In 2026

For marijuana stock investors, the way the industry as a whole progresses determines a great deal for them. For example, no one wants to invest in a struggling industry even if it's been trendy along the way. Now, cannabis has fallen to that path, but it's also what's making this industry one of the hottest sectors in the last 5 years. Legal cannabis has been a long uphill battle in every sense. Legislation and regulatory issues remain the biggest challenges.

Cannabis Rescheduling Could Unlock the Biggest MSO Rally Since 2021

Federal cannabis policy moved from theory to action this spring, and three ETFs sit closest to the trade.

24/7 Wall Street • May 6, 2026

Top Performing Leveraged/Inverse ETFs: 05/03/2026

Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.

ETF Trends • May 5, 2026

Trump's Rescheduling of Marijuana Is a Spark for Top Marijuana ETFs

After amassing enormous losses over the past five years, cannabis stocks received a much-needed shot in the arm last week when President Donald Trump announced plans to officially reschedule marijuana from Schedule I to Schedule III under the Controlled Substances Act (CSA).

MarketBeat • May 3, 2026

Focus: Companies with cannabis-based drugs eye IPOs, private funding boost after US reclassification

Companies developing cannabis-based medicines say U.S. moves to loosen restrictions on the drug could unlock private funding and the public markets, ​providing a lifeline to the struggling cannabis industry.

Reuters • Apr 30, 2026